undefined Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Telecommunication Services
Airtel Africa PLC (NSA:AIRTELAFRI) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth Amid Currency Headwinds
Despite inflationary pressures and currency devaluation, Airtel Africa PLC (NSA:AIRTELAFRI) reports robust growth in key segments. Sep 14, 2024
GuruFocus Research Drug Manufacturers
Adcock Ingram Holdings Ltd (JSE:AIP) (Q2 2024) Earnings Call Transcript Highlights: Steady Revenue Growth Amidst Operational Challenges
Adcock Ingram Holdings Ltd (JSE:AIP) reports a 1.4% revenue increase and a mixed performance across divisions in its Q2 2024 earnings call. Sep 14, 2024
GuruFocus Research Chemicals
Alexium International Group Ltd (ASX:AJX) (Q2 2024) Earnings Call Transcript Highlights: Revenue Decline, Margin Improvement, and Strategic Shifts
Despite a revenue dip, Alexium International Group Ltd (ASX:AJX) shows promising margin growth and strategic pivots to drive future gains. Sep 14, 2024
GuruFocus Research Media - Diversified
Ai-Media Technologies Ltd (ASX:AIM) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Improved Margins
Ai-Media Technologies Ltd (ASX:AIM) reports significant revenue growth, improved gross margins, and a profitable EBITDA position for the half-year. Sep 14, 2024
GuruFocus Research Metals & Mining
Anglo American PLC (JSE:AGL) Q2 2024 Earnings Call Transcript Highlights: Strong Cost Control Amid Revenue Decline
Despite a challenging market, Anglo American PLC (JSE:AGL) demonstrates resilience with improved EBITDA margins and significant cost savings. Sep 14, 2024
GuruFocus Research Personal Services
Apiam Animal Health Ltd (ASX:AHX) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Operational Performance
Apiam Animal Health Ltd (ASX:AHX) reports significant year-over-year increases in revenue, gross profit, and EBITDA for the first half of FY24. Sep 14, 2024
GuruFocus Research Travel & Leisure
Ainsworth Game Technology Ltd (ASX:AGI) (FY 2023) Earnings Call Transcript Highlights: Strong Revenue Growth Amidst Strategic Review
Ainsworth Game Technology Ltd (ASX:AGI) reports a 17% revenue increase and explores strategic opportunities for future growth. Sep 14, 2024
GuruFocus Research Media - Diversified
Ai-Media Technologies Ltd (ASX:AIM) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Investments
Ai-Media Technologies Ltd (ASX:AIM) reports a 7% revenue increase and significant EBITDA turnaround, with a focus on technology and market expansion. Sep 14, 2024
GuruFocus Research Biotechnology
Vivoryon Therapeutics NV (FRA:05Y) (H1 2024) Earnings Call Transcript Highlights: Strategic Shift Towards Kidney Disease Amid Financial Challenges
Vivoryon Therapeutics NV (FRA:05Y) reports significant progress in kidney disease research but faces increased financial strain and funding needs. Sep 14, 2024
GuruFocus Research Banks
Australian Finance Group Ltd (ASX:AFG) Q2 2024 Earnings Call Transcript Highlights: Strong Broker Network Growth Amidst Profit Decline
Australian Finance Group Ltd (ASX:AFG) reports a mixed performance with significant investments in technology and broker network expansion. Sep 14, 2024